Lombardi Comprehensive Cancer Center, Georgetown University Hospital — Washington D.C., District of Columbia

Lombardi Comprehensive Cancer Center, Georgetown University Hospital is a clinical research site located in Washington D.C., District of Columbia, United States 20007-2113.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Comprehensive Cancer Center, Georgetown University Hospital has participated in 1 clinical trials.

Therapeutic areas: Colorectal Cancer.

Sponsors: Kyowa Kirin Co., Ltd..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Comprehensive Cancer Center, Georgetown University Hospital?

Lombardi Comprehensive Cancer Center, Georgetown University Hospital has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Comprehensive Cancer Center, Georgetown University Hospital conducted?

Lombardi Comprehensive Cancer Center, Georgetown University Hospital has 1 clinical trials on record. Their work covers Colorectal Cancer.

Is Lombardi Comprehensive Cancer Center, Georgetown University Hospital accredited by Crixeo Health?

Lombardi Comprehensive Cancer Center, Georgetown University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Comprehensive Cancer Center, Georgetown University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.